Equities

CVS Group PLC

CVSG:LSE

CVS Group PLC

Health CareHealth Care Providers
  • Price (GBX)1,356.00
  • Today's Change-12.00 / -0.88%
  • Shares traded250.85k
  • 1 Year change35.60%
  • Beta1.2950
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year CVS Group PLC grew revenues 5.40% from 638.70m to 673.20m while net income improved 751.61% from 6.20m to 52.80m.
Gross margin42.44%
Net profit margin2.84%
Operating margin7.40%
Return on assets2.76%
Return on equity6.75%
Return on investment3.34%
More ▼

Cash flow in GBPView more

In 2025, CVS Group PLC did not generate a significant amount of cash. However, the company earned 82.10m from its operations for a Cash Flow Margin of 12.20%. In addition the company used 22.70m on investing activities and also paid 59.20m in financing cash flows.
Cash flow per share1.17
Price/Cash flow per share11.38
Book value per share4.18
Tangible book value per share-0.5269
More ▼

Balance sheet in GBPView more

CVS Group PLC has a Debt to Total Capital ratio of 45.20%, a lower figure than the previous year's 105.18%.
Current ratio1.10
Quick ratio0.867
Total debt/total equity0.8299
Total debt/total capital0.452
More ▼

Growth rates in GBP

Year on year, growth in dividends per share increased 6.25% while earnings per share excluding extraordinary items fell by -22.96%. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.45%
Div growth rate (5 year)--
Payout ratio (TTM)32.28%
EPS growth(5 years)26.70
EPS (TTM) vs
TTM 1 year ago		-23.06
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.